These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8278595)

  • 21. Cooperation between D1- and D2-dopamine receptors in the nucleus accumbens.
    Szmigielski A; Zalewska-Kaszubska J
    Neuropharmacology; 1991 Mar; 30(3):259-66. PubMed ID: 1830133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of D1 and D2 antagonists on apomorphine-induced responses of ventral pallidal neurons.
    Maslowski RJ; Napier TC
    Neuroreport; 1991 Aug; 2(8):451-4. PubMed ID: 1832988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic lithium pretreatment on apomorphine-induced penile erection.
    Dehpour AR; Samini M; Sharifzadeh M; Hasan-Mazandarani H
    Gen Pharmacol; 1995 Sep; 26(5):1015-20. PubMed ID: 7557243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR; Carey RJ; Carrera MP
    Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.
    Mattingly BA; Rowlett JK; Graff JT; Hatton BJ
    Psychopharmacology (Berl); 1991; 105(4):501-7. PubMed ID: 1837610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge.
    Daunais JB; McGinty JF
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):237-48. PubMed ID: 8717360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
    Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural motor effects of MK-801 and DNQX parenteral administration in adult cats: dose-response analysis. Modulatory role of dopaminergic D1 and D2 antagonists on MK-801 induced motor behaviours.
    Motles E; Infante C; Gonzalez M
    Arch Ital Biol; 2000 Apr; 138(2):167-74. PubMed ID: 10782256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR; Tabatabai SA
    Psychopharmacology (Berl); 1992; 107(2-3):341-6. PubMed ID: 1535446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
    Ongini E; Caporali MG
    Neuropharmacology; 1987 Apr; 26(4):355-60. PubMed ID: 2953987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apparent enhancement by SCH 23390 of apomorphine-induced locomotor activity in mice.
    Matsumoto K; Cai B; Ohta H; Imamura L; Watanabe H
    Pharmacol Biochem Behav; 1991 Jul; 39(3):699-703. PubMed ID: 1784598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acute and chronic lead exposure on apomorpine-induced sniffing in rats.
    Fazli-Tabaei S; Fahim M; Zarrindast MR
    Pharmacol Toxicol; 2003 Feb; 92(2):88-93. PubMed ID: 12747578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine.
    Mattingly BA; Hart TC; Lim K; Perkins C
    Psychopharmacology (Berl); 1994 Mar; 114(2):239-42. PubMed ID: 7838914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A
    Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis.
    Herman JP; Rouge-Pont F; Le Moal M; Abrous DN
    Neuroscience; 1993 Apr; 53(4):1083-95. PubMed ID: 8099430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.